TTrialPathMatch Me to Trials
← Back to trials
RecruitingTricuspid Valve RegurgitationHeart Valve DiseasesCardiovascular Diseases

The TRICURE EFS Study

Eligible age

18+ yrs

Accepts

All genders

Locations

7 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

Sponsor: TRiCares

You may qualify if…

  • Adult patients
  • Tricuspid regurgitation grade 3 (severe) on a scale of 0 (none) to 5 (torrential)
  • Institutional Heart Team evaluates patient as being at increased operative risk

You may not qualify if…

  • Patient in need of emergent intervention
  • Patient who is hemodynamically unstable
  • Anatomical contraindications for implantation with study device
  • Patient who is currently participating in another clinical investigation where the primary endpoint was not reached yet

Where it's recruiting

Georgia

Atlanta

Illinois

Chicago

Michigan

Ann Arbor

Minnesota

Minneapolis

New York

New York · The Bronx

Ohio

Cincinnati

South Carolina

Charleston

Source: ClinicalTrials.gov · NCT06506942 · last updated 2026-07-23

The TRICURE EFS Study · TrialPath